Baseline characteristics and risk profiles of 1111 patients with primary biliary cholangitis (PBC) in need of second-line therapy

被引：0
|
作者：
Hirschfield, Gideon [1 ,2 ]
Kowdley, Kris [3 ]
Kremer, Andreas E. [4 ]
Vierling, John M. [5 ]
Bowlus, Christopher [6 ]
Levy, Cynthia [7 ]
Mayo, Marlyn J. [8 ]
Crittenden, Daria B. [9 ]
Standen, Mary [9 ]
Yang, Ke [9 ]
Choi, Yun-Jung [9 ]
McWherter, Charles [9 ]
机构：
[1] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada
[2] Div Gastroenterol & Hepatol, Toronto, ON, Canada
[3] Liver Inst Northwest, Seattle, WA USA
[4] Univ Hosp Zurich, Zurich, Switzerland
[5] Baylor Coll Med, Houston, TX USA
[6] Univ Calif Davis, Sch Med, Sacramento, CA USA
[7] Univ Miami, Miller Sch Med, Schiff Ctr Liver Dis, Miami, FL USA
[8] Univ Texas Southwestern, Dallas, TX USA
[9] CymaBay Therapeut, Newark, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
WED-256
引用
收藏
页码：S371 / S372
页数：2
相关论文
共 50 条
  • [41] First and second-line therapy of high-risk MDS patients
    Platzbecker, U.
    ONKOLOGIE, 2013, 36 : 22 - 22
  • [42] Real-world evaluation of second line therapy in Primary Biliary Cholangitis: A multicentre nationwide study
    Abbas, Nadir
    Culver, Emma
    Thorburn, Douglas
    Halliday, Neil
    Crothers, Hannah
    Dyson, Jessica
    Aspinall, Richard
    Kallis, Yiannis
    Smith, Belinda
    Patanwala, Imran
    McCune, Anne
    Chimakurthi, Chenchu
    Jones, Rebecca L.
    Orrell, Michael
    Mells, George
    Jones, David
    Hirschfield, Gideon
    Trivedi, Palak
    JOURNAL OF HEPATOLOGY, 2021, 75 : S426 - S427
  • [43] Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa
    Onoya, Dorina
    Nattey, Cornelius
    Budgell, Eric
    van den Berg, Liudmyla
    Maskew, Mhairi
    Evans, Denise
    Hirasen, Kamban
    Long, Lawrence C.
    Fox, Matthew P.
    AIDS PATIENT CARE AND STDS, 2017, 31 (05) : 205 - 212
  • [44] TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC): BASELINE DATA FROM THE PHASE 2b GLIMMER TRIA
    Smith, Helen
    Das, Sugato
    Currie, Alexander
    De Souza, Andrea Ribeiro
    McLaughlin, Megan M.
    HEPATOLOGY, 2022, 76 : S1473 - S1474
  • [45] Editorial: Unravelling real-world impact of second-line therapies in primary biliary cholangitis: Time to change our targets?
    Cancado, Guilherme Grossi Lopes
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (01) : 89 - 90
  • [46] Outcomes and Characteristics of Patients Receiving Second-line Therapy for Advanced Pancreatic Cancer
    Tsang, Erica S.
    Wong, Hui-li
    Wang, Ying
    Renouf, Daniel J.
    Cheung, Winson Y.
    Lim, Howard J.
    Gill, Sharlene
    Loree, Jonathan M.
    Kennecke, Hagen F.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (02): : 196 - 201
  • [47] Outcomes and characteristics of patients receiving second-line therapy for advanced pancreatic cancer
    Tsang, Erica S.
    Wong, Hui-Li
    Wang, Ying
    Renouf, Daniel John
    Cheung, Winson Y.
    Lim, Howard John
    Gill, Sharlene
    Loree, Jonathan M.
    Kennecke, Hagen F.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [48] SECOND-LINE THERAPY IN ADVANCED BILIARY TRACT CANCER: BASELINE DATA FROM A RETROSPECTIVE MULTI-CENTRE SERIES
    Bridgewater, J. A.
    Palmer, D.
    Cunningham, D.
    Iveson, T.
    Gillmore, R.
    Waters, J.
    Harrison, M.
    Valle, J. W.
    Wasan, H.
    Corrie, P.
    ANNALS OF ONCOLOGY, 2012, 23 : 242 - 243
  • [49] Second line therapy in patients with primary biliary cholangitis and inadequate response to UDCA: are we choosing the right target population for clinical trials?
    Villamil, Alejandra
    de la Vina, Daniela
    Mullen, Eduardo
    Lucero, Ignacio
    Sobenko, Natalia
    Bandi, Juan Carlos
    JOURNAL OF HEPATOLOGY, 2024, 80 : S342 - S343
  • [50] Stratification of hepatocellular carcinoma risk using the GLOBE score in patients with primary biliary cholangitis-the Global PBC Study Group
    Lammers, W. J.
    Trivedi, P.
    Hirschfield, G.
    Corpechot, C.
    Floreani, A.
    Nevens, F.
    Thorburn, D.
    Pares, A.
    Kowdley, K. V.
    Larusso, N.
    Battezzati, P. M.
    Ponsioen, C.
    Mason, A. L.
    Mayo, M. J.
    Invernizzi, P.
    Bruns, T.
    Dalekos, G.
    Xavier, V.
    Harms, M.
    Goet, J.
    Lindor, K.
    Janssen, H.
    Hansen, B.
    Van Buuren, H.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S229 - S230
12345